Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy-Reference-Cited by-同舟云学术

Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy

Published:2017-04 Issue:4 Volume:129 Page:707-714
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Eck Lasse Karlsen,Jensen Thomas Bo,Mastrogiannis Dimitrios,Torp-Pedersen Arendse,Askaa Bjarke,Nielsen Torben Kjær,Poulsen Henrik Enghusen,Jimenez-Solem Espen,Andersen Jon Trærup

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference27 articles.

1. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative;Visser;Ann Rheum Dis,2009

2. Pharmacogenetics of methotrexate;Krajinovic;Pharmacogenomics,2004

3. Methotrexate pharmacology [in French];Lagarce;J Gynécologie Obstétrique Biol Reprod (Paris),2015

4. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study;Weber-Schoendorfer;Rheumatology (Oxford),2014

5. Paternal exposure to methotrexate and pregnancy outcomes;Beghin;J Rheumatol,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications;Journal of Clinical Medicine;2024-02-22

2. Where are the data to assess the safety of paternal drug exposure? A systematic review of secondary databases: A contribution from IMI concePTION;Pharmacoepidemiology and Drug Safety;2024-02

3. Methotrexate use among men—association with fertility and the perinatal health of their children: a Swedish nationwide register study;Fertility and Sterility;2023-09

4. Prescribing for pregnancy: inflammatory rheumatic disease;Drug and Therapeutics Bulletin;2023-01-25

5. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids;Rheumatology;2022-11-02